Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrogen In Neonatal Encephalopathy (HIE) Trial
NCT07411911Phase 1Not yet recruiting
- Sponsor
- Boston Children's Hospital
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- Inhalation Devices, Small Molecules
01
Overview
Phase 1, randomised trial in hypoxic-ischemic encephalopathy (HIE) comparing Hydrogen Gas (H2) Intervention with Standard of Care (2 arms). Primary endpoints: Hydrogen Gas Administration Safety at 30 days and Hydrogen Gas Administration Feasibility at 72 hours. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
Molecular hydrogen
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT07411911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07411911.